top of page


News


Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
Tel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased...
Jun 4, 2020


Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT
Introduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a...
Jun 3, 2020


Alpha Tau Medical Announces Exclusive Distribution Arrangement with Medison Canada For Breakthrough
Tel Aviv, Israel -- Alpha Tau Medical – the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, and Medison Canada – a...
Apr 7, 2020


Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Nov 26, 2019


Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Sep 5, 2018
bottom of page








